BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 17556356)

  • 1. Crystal structure of human estrogen-related receptor alpha in complex with a synthetic inverse agonist reveals its novel molecular mechanism.
    Kallen J; Lattmann R; Beerli R; Blechschmidt A; Blommers MJ; Geiser M; Ottl J; Schlaeppi JM; Strauss A; Fournier B
    J Biol Chem; 2007 Aug; 282(32):23231-9. PubMed ID: 17556356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for ligand-independent transcriptional activation of the human estrogen-related receptor alpha (ERRalpha): crystal structure of ERRalpha ligand binding domain in complex with peroxisome proliferator-activated receptor coactivator-1alpha.
    Kallen J; Schlaeppi JM; Bitsch F; Filipuzzi I; Schilb A; Riou V; Graham A; Strauss A; Geiser M; Fournier B
    J Biol Chem; 2004 Nov; 279(47):49330-7. PubMed ID: 15337744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis for the deactivation of the estrogen-related receptor gamma by diethylstilbestrol or 4-hydroxytamoxifen and determinants of selectivity.
    Greschik H; Flaig R; Renaud JP; Moras D
    J Biol Chem; 2004 Aug; 279(32):33639-46. PubMed ID: 15161930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the binding mode and thermodynamics of inverse agonists against estrogen-related receptor alpha.
    Karnati KR; Wang Y; Du Y
    RSC Adv; 2020 Apr; 10(28):16659-16668. PubMed ID: 35498853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel inverse agonists of estrogen-related receptors ERRγ and ERRβ.
    Yu DD; Huss JM; Li H; Forman BM
    Bioorg Med Chem; 2017 Mar; 25(5):1585-1599. PubMed ID: 28189393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. X-ray crystal structures of the estrogen-related receptor-gamma ligand binding domain in three functional states reveal the molecular basis of small molecule regulation.
    Wang L; Zuercher WJ; Consler TG; Lambert MH; Miller AB; Orband-Miller LA; McKee DD; Willson TM; Nolte RT
    J Biol Chem; 2006 Dec; 281(49):37773-81. PubMed ID: 16990259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural insights into the mode of action of a pure antiestrogen.
    Pike AC; Brzozowski AM; Walton J; Hubbard RE; Thorsell AG; Li YL; Gustafsson JA; Carlquist M
    Structure; 2001 Feb; 9(2):145-53. PubMed ID: 11250199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Communication between the ERRalpha homodimer interface and the PGC-1alpha binding surface via the helix 8-9 loop.
    Greschik H; Althage M; Flaig R; Sato Y; Chavant V; Peluso-Iltis C; Choulier L; Cronet P; Rochel N; Schüle R; Strömstedt PE; Moras D
    J Biol Chem; 2008 Jul; 283(29):20220-30. PubMed ID: 18441008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into the interaction mechanisms of estrogen-related receptor alpha (ERRα) with ligands via molecular dynamics simulations.
    Li D; Cai Y; Teng D; Wu Z; Li W; Tang Y; Liu G
    J Biomol Struct Dyn; 2020 Aug; 38(13):3867-3878. PubMed ID: 31498028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coactivator proteins as determinants of estrogen receptor structure and function: spectroscopic evidence for a novel coactivator-stabilized receptor conformation.
    Tamrazi A; Carlson KE; Rodriguez AL; Katzenellenbogen JA
    Mol Endocrinol; 2005 Jun; 19(6):1516-28. PubMed ID: 15661830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen-related receptor alpha and estrogen-related receptor gamma associate with unfavorable and favorable biomarkers, respectively, in human breast cancer.
    Ariazi EA; Clark GM; Mertz JE
    Cancer Res; 2002 Nov; 62(22):6510-8. PubMed ID: 12438245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of a mutant hERalpha ligand-binding domain reveals key structural features for the mechanism of partial agonism.
    Gangloff M; Ruff M; Eiler S; Duclaud S; Wurtz JM; Moras D
    J Biol Chem; 2001 May; 276(18):15059-65. PubMed ID: 11278577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformational changes and coactivator recruitment by novel ligands for estrogen receptor-alpha and estrogen receptor-beta: correlations with biological character and distinct differences among SRC coactivator family members.
    Kraichely DM; Sun J; Katzenellenbogen JA; Katzenellenbogen BS
    Endocrinology; 2000 Oct; 141(10):3534-45. PubMed ID: 11014206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and functional characterization of a novel endogenous inverse agonist of estrogen related receptors (ERRs) from human pregnancy urine.
    Ghanbari F; Hebert-Losier A; Barry J; Poirier D; Giguere V; Mader S; Philip A
    J Steroid Biochem Mol Biol; 2019 Jul; 191():105352. PubMed ID: 30954508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A characteristic back support structure in the bisphenol A-binding pocket in the human nuclear receptor ERRγ.
    Liu X; Matsushima A; Shimohigashi M; Shimohigashi Y
    PLoS One; 2014; 9(6):e101252. PubMed ID: 24978476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligands differentially modulate the protein interactions of the human estrogen receptors alpha and beta.
    Margeat E; Bourdoncle A; Margueron R; Poujol N; Cavaillès V; Royer C
    J Mol Biol; 2003 Feb; 326(1):77-92. PubMed ID: 12547192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of novel 4-hydroxytamoxifen analogs as estrogen-related receptor gamma inverse agonists.
    Kim J; Chin J; Im CY; Yoo EK; Woo S; Hwang HJ; Cho JH; Seo KA; Song J; Hwang H; Kim KH; Kim ND; Yoon SK; Jeon JH; Yoon SY; Jeon YH; Choi HS; Lee IK; Kim SH; Cho SJ
    Eur J Med Chem; 2016 Sep; 120():338-52. PubMed ID: 27236015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist.
    Pike AC; Brzozowski AM; Hubbard RE; Bonn T; Thorsell AG; Engström O; Ljunggren J; Gustafsson JA; Carlquist M
    EMBO J; 1999 Sep; 18(17):4608-18. PubMed ID: 10469641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and in vitro biological evaluation of small molecule inhibitors of estrogen receptor alpha coactivator binding.
    Rodriguez AL; Tamrazi A; Collins ML; Katzenellenbogen JA
    J Med Chem; 2004 Jan; 47(3):600-11. PubMed ID: 14736241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational insights into the interaction mechanisms of estrogen-related receptor alpha with endogenous ligand cholesterol.
    Li D; Cai Y; Teng D; Li W; Tang Y; Liu G
    Chem Biol Drug Des; 2019 Jul; 94(1):1316-1329. PubMed ID: 30811808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.